Clinical usefulness of assessment of ankle-brachial index and carotid stenosis in type 2 diabetic population-three-year cohort follow-up of mortality

Angiology

Volumn 64, Issue 1, 2013, Pages 64-68

  Bosevski, Marijan ^a   Peovska, Irena ^a  

^a University Cardiology Clinic   (Macedonia)

Author keywords

ankle brachial index; carotid stenosis; mortality; prognosis; type 2 diabetes

Indexed keywords

ADULT; AGE DISTRIBUTION; ANKLE BRACHIAL INDEX; ARTICLE; CARDIOVASCULAR MORTALITY; CAROTID ARTERY OBSTRUCTION; COHORT ANALYSIS; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREDICTION; PROGNOSIS; SCORING SYSTEM;

AGED; ANKLE BRACHIAL INDEX; CAROTID STENOSIS; COHORT STUDIES; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; ULTRASONOGRAPHY, DOPPLER;

EID: 84870878199     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319711435936     Document Type: Article

References (42)

1. Berry J, Keebler ME, McGuire DK. Diabetes mellitus and cardiovascular disease: Pandora's box has been opened. Herz. 2004 ; 29: 456-462 (Pubitemid 39166101)
2. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004 ; 291 (3). 335-342 (Pubitemid 38101606)
3. Grundy SM, Howard B, Smith S, et al. Diabetes and cardiovascular disease: AHA executive summary. Circulation. 2002 ; 105 (18). 2231-2239
4. Rydén L, Standl E, Bartnik M, et al. Task force members on diabetes and cardiovascular diseases of the ESC and EASD. Guidelines on diabetes, pre-diabetes, and cardiovascular disease. Eur Heart J. 2007 ; 28 (1). 88-136
5. Morrish NJ, Steven LK, Head J, et al. A prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO multinational study of vascular disease in diabetics). Diabetologia. 1990 ; 33 (9). 542-548 (Pubitemid 20293161)
6. Bernard S, Serusclar A, Targe F, et al. Incremental predictive value of carotid ultrasonography in the assessment of coronary risk in a cohort of asymptomatic type 2 diabetic subjects. Diabetes Care. 2005 ; 28 (5). 1158-1159
7. Parikh A, Daneman D. Is carotid ultrasound a useful tool in assessing cardiovascular disease in individuals with diabetes?. Diabetes Technol Ther. 2004 ; 6 (1). 65-69 (Pubitemid 38233749)
8. Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care. Diabet Med. 2006 ; 23 (6). 579-593
9. Ozeke O, Aras D, Deveci B, et al. Comparison of presence and extent of coronary narrowing in patients with left bundle branch block without diabetes mellitus to patients with and without left bundle branch block but with diabetes mellitus. Am J Cardiol. 2006 ; 97 (6). 857-859
10. Hu G, Jousilahti P, Qiao Q, Katoh S, Tuomilehto J. Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction. Diabetologia. 2005 ; 48 (5). 856-861 (Pubitemid 40767977)
11. Panzram G. Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1987 ; 30 (3). 123-131 (Pubitemid 17056996)
12. Lotufo PA, Gaziano JM, Chae CU, et al. Diabetes and all-cause and coronary heart disease mortality among US male physicians. Arch Intern Med. 2001 ; 161 (2). 242-247 (Pubitemid 32102391)
13. Uusitupa MI, Niskanen LK, Siitonen O, Voutilainen E, Pyörä lä K. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia. 1993 ; 36 (11). 1175-1184 (Pubitemid 23314569)
14. Miettinen H, Lehto S, Salomaa V, et al. Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care. 1998 ; 21 (1). 69-75 (Pubitemid 28030388)
15. Norhammar A, Tenerz A, Nisson G. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet. 2002 ; 359 (9324). 2140-2144 (Pubitemid 34694020)
16. Panser LA, Naessens JM, Nobrega FT, Palumbo PJ, Ballard DJ. Utilization trends and risk factors for hospitalization I diabetes mellitus. Mayo Clinic Proc. 1990 ; 65 (9). 1171-1184 (Pubitemid 20332181)
17. Goyder EC, Spiers N, McNally PG, Drucquer M, Botha JL. Do diabetes clinic attendees stay out of hospital? A matched case control study. Diabet Med. 1999 ; 16 (8). 687-691
18. Bruno G, Merelti F, Biggeri A, et al. Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in Type 2 diabetes. Diabetes Care. 2004 ; 27 (11). 2689-2694 (Pubitemid 39441471)
19. Lowe LP, Liu K, Greenland P, Metzger BE, Dyer AR, Stamler J. Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men. The Chicago Heart Association Detection Project in Industry Study. Diabetes Care. 1997 ; 20 (2). 163-169 (Pubitemid 27051554)
20. Fuller JH, Stevens LK, Wang SL. Risk factors for cardiovascular mortality and morbidity: the WHO multinational study of vascular disease in diabetes. Diabetologia. 2001 ; 44 (suppl 2). S54 - S64
21. Capes S, Hunt D, Malmberg K, Gerstein H. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systemic review. Lancet. 2000 ; 164: 982-988
22. Stranders I, Diamanat M, van Gelder R. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med. 2004 ; 164 (9). 982-988 (Pubitemid 38581518)
23. Barsness GW, Gersh BJ, Brooks MM, Frye RLF. Rationale for the Revascularization Arm of the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2 D) Trial. Am J Cardiol. 2006 ; 97 (suppl 1). 31G - 40G
24. Pyorala M, Miettinen H, Laakso M, Pyorala K. Plasma insulin and all-cause, cardiovascular and non-cardiovascular mortality: the 22 year follow up results of the Helsinki Policemen Study. Diabetes Care. 2000 ; 23 (8). 1097-1102 (Pubitemid 30616795)
25. Skyler JS, Bergenstal R, Bonow RO, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD. Diabetes Care. 2009 ; 32 (1). 187-192
26. Held C, Hjemdahl P, Eriksson SV, Bjonkander I, Forslund L, Rehnqvist N. Prognostic implications of intima-media thickness and plaque in the carotid and femoral arteries in patients with stable angina pectoris. Eur Heart J. 2001 ; 22 (1). 62-72 (Pubitemid 32622190)
27. Bots ML, Bladassarre D, Simon A, et al. Carotid intima-media thickness and coronary atherosclerosis: weak or strong relations?. Eur Heart J. 2007 ; 28 (4). 398-406 (Pubitemid 47343565)
28. Peters SA, Ruijter HM, Bots ML, Moons KG. Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review. Heart. 2012 ; 98 (3). 177-184
29. Serebruany VL, Malinin AI, Pokov A, Barsness G, Hanley DF. Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in diabetic patients: the PLavix Use for Treatment Of Diabetes (PLUTO-Diabetes) trial. Am Heart J. 2008 ; 155 (93). e1 - e7
30. De Berardis G, Sacco M, Evangelista V, et al. for ACCEPT-D Study Group. Aspirin and simvastatin combination for cardiovascular events prevention trial in diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins. Trials. 2007 ; 8: 21
31. Lorenz MW, Markus HS, Bots MI, et al. Prediction of clinical cardiovascular events with carotid intima-media thickness. Circulation. 2007 ; 115 ( 4 ):
32. Lee EJ, Kim HJ, Bae JM, et al. Relevance of common carotid intima-media thickness and carotid plaque as risk factors for ischemic stroke in patients with type 2 diabetes mellitus. Am J Neuroradiol. 2007 ; 28 (5). 916-919 (Pubitemid 46776074)
33. Spence JD. Ultrasound measurements of carotid plaques as a surrogate outcome for coronary artery disease. Am J Cardiol. 2002 ; 89 (suppl). 10B - 16B (Pubitemid 34185515)
34. Giral P, Brucket E, Daiorrou F. Usefulness in predicting coronary artery disease by ultrasonic evaluation of the carotid arteries in asymptomatic hypercholesterolemic patients with positive exercise stress test. Am J Cardiol. 1999 ; 84 (1). 14-17 (Pubitemid 29307634)
35. Bosevski M, Borozanov V, Vavlukis M, Pemovska G, Georgievska-Ismail LJ. Carotid ultrasound, blood lipids and waist determination can predict a future coronary revascularisation in the type 2 diabetic cohort. Prilozi. 2007 ; 28 (2). 127-136
36. Paraskevas KI, Kotsikoris I, Koupidis SA, Giannoukas AD, Mikhailidis DP. Ankle-brachial index: a marker of both peripheral arterial disease and systemic atherosclerosis as well as a predictor of vascular events. Angiology. 2010 ; 61 (6). 521-523
37. Bosevski M, Kostoska S, Tosev S, Borozanov V. Prognostic importance of haemostatic parameters in polyarterial disease. Prilozi. 2005 ; 26 (1). 81-92
38. Long-term survival in patients with coronary artery disease: the importance of peripheral arterial disease. JACC. 1994 ; 23 (5). 1091-1095
39. Nodari S, Manerba A, Vaccari A, et al. Six-year prognosis of diabetic patients with coronary artery disease. Eur J Clin Invest. 2011 ;:
40. Norman PE, Davis WA, Bruce DG, Davis TM. Peripheral arterial disease and risk of cardiac death in type 2 diabetes. The Fremantile Diabetes study. Diabetes Care. 2006 ; 29 (3). 575-580 (Pubitemid 44115357)
41. Mihara T, Oohashi H, Hirata Y. Mortality of Japanese diabetics in a seven-year follow-up study. Diabetes Res Clin Pract. 1986 ; 2 (3). 139-144 (Pubitemid 17231069)
42. Lebson CL, Ransom JE, Olsen W, Zimertman BR, O'Fallon WM, Palumbo PJ. Peripheral artery disease, diabetes and mortality. Diabetes Care. 2004 ; 27 (12). 2843-2849 (Pubitemid 39565047)